The first report, which TFHC published for their members and network, addresses the International Opportunities and Bottlenecks in international business. TFHC makes every effort to support Dutch companies when they do business across the border. It is important to clarify that organisations need to recognise the opportunities and problems so that the interests of TFHC members can be aligned. The study shows that the vast majority of companies are exporting to more than one country, thereby increasing their international market. Additionally, a positive trend can be seen in the number of companies exporting to more than 25 countries. Furthermore, results from the past few years demonstrate that the top-10 export markets are reasonably stable. For many years, the neighbouring European countries of Germany, the United Kingdom and Belgium have formed a traditional top-3 for exports.
International Opportunities and Export Support
Recently, the Task Force Health Care (TFHC) published two important reports on international business opportunities and export support. These reports are informative for Dutch Life Sciences & Health companies that want to enter the international market.
Besides international opportunities, TFHC in collaboration with FME (trade association for the technology industry) has created a brief and clear overview on export support for SMEs. This overview explains the different grants schemes and other tools the Dutch government offers in the area of international business. The aim of this report is to create a better understanding of the quantity and diversity of supportive government instruments in international business. The Dutch government supports a wide variety of export activities and cooperation and solves issues, e.g. financial bottlenecks or other obstacles, which an international entrepreneur can come up against. The complete overview can be found here.
Encouraging European Research
Publicly funded knowledge institutions, that are included in the target group list and that acquire European funds within Horizon2020, are eligible for a funding via the Encouraging European Research regulation.
With effect from 2015, the Ministry of Education, Culture and Science, in alignment with the Ministry of Economic Affairs, has made extra funding available for publicly funded knowledge institutions that acquire European funds within Horizon2020. This funding will be provided via the so-called 'Encouraging European Research' (EER) regulation. This regulation makes a contribution towards the costs that institutions incur directly or indirectly for an EU-funded project.
The budget of the Encouraging European Research fund is 50 million euros and throughout the duration of Horizon2020 it is expected to remain at a similar level each year. The intention is that throughout the entire duration of Horizon2020 the funds will be entirely available to the institutions.
The aim of Encouraging European Research regulations is to increase Dutch participation of the publicly funded knowledge institutions in EU programmes for research and innovation and forms part of the policy to strengthen the Dutch knowledge and innovation system.
With these funds successful knowledge institutions will effectively and efficiently receive a contribution towards the costs, in addition to the European project grants they have managed to acquire. This regulation will therefore encourage active participation of the publicly funded knowledge institutions in European research programmes.
Funds from the Encouraging European Research regulation cannot be applied for. These are awarded to publicly funded knowledge institutions on the basis of contracts concluded within Horizon2020. The target group has been set by the Ministry of Education, Culture and Science and is not final. The target group list is updated twice annually, both in Spring and in Autumn. In November and December these funds are awarded by NWO on the basis of the contracts concluded within Horizon2020 in the previous year.
Health~Holland Pavilion travels to BIO Europe 2015
Health~Holland present at leading partnering event, 2-4 November in Munich, Germany.
In collaboration with Healthy Ageing Network Northern Netherlands (HANNN), a Health~Holland pavilion will be present at BIO Europe 2015, presenting the strengths of the Dutch Life Sciences sector. BIO Europe is Europe’s largest partnering conference and serves the global biotechnology industry. The annual conference attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. Some 3,300 life sciences dealmakers are expected to attend this twenty-first BIO Europe. An excellent opportunity to present the Dutch Life Sciences & Health sector, according to Top Sector LSH.
The next issue of Health~Holland Update will contain a report on BIO Europe 2015. Please contact Naomi Vorstermans for more information. NB: HollandBIO members can receive a 300 euros discount on the registration fee for BIO Europe. Contact HollandBIO to find out more.
Health~Holland at the MEDICA in Düsseldorf
MEDICA continues to be one of the most important exhibition for the Dutch Top Sector Life Sciences & Health and was therefore appointed as one of the Top Sector’s two strategic trade fairs. With more than 132,000 visitors and 4800 exhibitors MEDICA 2015 is the biggest trade fair for the healthcare and medical technology industry. The latest medical product presentations combined with the many international network opportunities provides the best meeting place for specialists, investors, agents, distributors and professionals from more than 120 countries. And more important still, MEDICA is the world's largest medical marketplace where supply meets demand.
Powered by Health~Holland, the Task Force Health Care (TFHC) and FME organise the Dutch presence at MEDICA in Düsseldorf by coordinating the Holland Pavilion. This allows Dutch companies and organization to tap into a global network and boost their national and international activities.
For more information contact the TFHC.
European Biotech Week: Celebrating Innovation
The European Biotech Week comprises a weeklong series of events celebrating biotechnology.
The first European Biotech Week took place in 2013, marking the 60th anniversary the discovery of the DNA molecule back in 1953. Thanks to that discovery, the deeper knowledge of genes, proteins, viruses, bacteria and genetic structures in general has allowed scientists and biotech entrepreneurs to translate knowledge into applications in sectors such as healthcare, agriculture, food, energy, water sanitation and biochemical processing, all of which have changed the world for the better.
If you are looking to plan any biotech related event between 12 and 18 October 2015, large or small, the European biotech industry organisation EuropaBIO would be happy to hear from you! Visit Biotechweek or contact Annika van Rosmalen from HollandBIO for more information.